what is the minimum bmi for semaglutide BMI for GLP-1: body mass index do you actually need to qualify BMI for Mounjaro: Considerations for

WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

A provider-guided review can help determine whether approved medical weight-loss care, peptide therapy, hormone evaluation, nutrition support, or longevity care is a safer option

Martinez E, Domingo P, Roca-Cusachs A

Table 1) and vice versa (Figure 2G

However, semaglutide has a longer track record, more post-market safety data, and wider availability in Mexican pharmacies